Comparison Of The Antiplatelet Effect Between Ticagrelor And Clopidogrel In Chinese Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY(2016)
摘要
Background: Ticagrelor can provide effective platelet inhibition 2 hours after a loading dose, but it will take 6 hours for clopidogrel. It is not very clear whether the anthplatelet agents treated patients with AMI undergoing primary PCI can achieve ideal antiplatelet effect after 24 to 48 hours. Purpose: The aim is to compare the antiplatelet action between ticagrelor and clopidogrel in Chinese patients with AMI after primary PCI. Methods: 189 patients with AMI after primary PCI were enrolled in this single center registry. All patients received loading and maintenance dose of dual antiplatelet therapy (aspirin+clopidogrel/ticagrelor). 58 cases were included in ticagrelor group. 131 patients were included in clopidogrel group. Residual platelet reactivity was assessed by VerifyNow 24-48 hours after PCI. All patients were followed-up for 30 days and 6 months after discharge. Results: The baseline data were well matched between the two groups. After 24-48 hours, 51 cases existed of high residual platelet response(HRPR)(platelet response unit ,PRU≥230), the ratio was 26.98%. In clopidogrel group, the average PRU was 195.8 (26~329), and 43 patients existed HRPR, ratio was 32.82%. For ticagrelor group, the average PRU was 101.8 (6~322), and 8 patients existed HRPR, ratio was 14.04%. The incidence of HRPR was significantly lower in ticagrelor group ( p < 0.0001). Within 30 days, the incidence of MI in clopidogrel group and ticagrelor group were respectively 0.8% and 0, p =0.693; target lesion revascularization were 1.7% and 1.5%, p =0.669; death were 0.8% and 0, p =0.693; stroke were 0 and 0, p =1.000; bleeding were 2.3% and 0, p =0.331. In 6 months, the incidence of MI were 0.8% and 0, p =0.693; target lesion revascularization were 0.8% and 0, p =0.693; death were 0 and 0, p =1.000. The incidence of MACE, bleeding and stroke had no obvious difference between the two groups. Conclusion: 24 hours after primary PCI, there are still a large proportion of Chinese patients with AMI existing insufficient platelet inhibition, no matter they take clopidogrel or ticagrelor, but ticagrelor has a significant stronger antiplatelet effect than clopidogrel. There is no obvious difference between the incidences of clinical events.
更多查看译文
关键词
acute myocardial infarction,myocardial infarction,primary percutaneous coronary intervention,percutaneous coronary intervention,ticagrelor
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要